| Category | BioTech |
| Employees | |
| Founded | 7/11 |
| TOTAL | $10.2M |
| VENTURE FUNDING TOTAL | $10.2M |
| Series A, 10/11 Sofinnova Partners Forbion Capital Partners | €7M |
Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines. Founded in July 2011, in Austria, Hookipa Biotech has developed a proprietary technology platform, VaxwaveTM, dedicated to genetic vaccines for the prophylactic and therapeutic treatment of viral diseases. VaxwaveTM introduces a new approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity; the platform has been validated in different disease models. The company will use the Series A funds to advance its lead product HB101 through pre-clinical development and a Phase I proof of concept study, and to further industrialize and validate the VaxwaveTM technology.
